[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353511-105":59,"doc-detail-353511-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-the-hsp60p53-axis-with-extracellular-vesicle-delivered-sirna-reprograms-glycolysis-in-prostate-cancer","Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer","","Prostate cancer remains a major therapeutic challenge due to limited targeted strategies. This study examines heat shock protein 60 (HSP60) and develops siRNA-loaded extracellular vesicles (siRNA@EVs) for prostate cancer targeted therapy. Bioinformatics, qPCR, and Western blot validate HSPD1 overexpression, while metabolomic-transcriptomic integration links HSP60 to glycolytic reprogramming. EVs are produced from UV-irradiated cells, delivered by electroporation, and tested in vitro and in xenografts. Multi-omics analyses associate HSP60 with advanced progression and poor prognosis; knockdown and pharmacologic inhibition suppress growth and metastasis via p53 suppression, and siRNA@EVs show efficacy with safety in nude mice.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-the-hsp60p53-axis-with-extracellular-vesicle-delivered-sirna-reprograms-glycolysis-in-prostate-cancer/353511/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-the-hsp60p53-axis-with-extracellular-vesicle-delivered-sirna-reprograms-glycolysis-in-prostate-cancer/353511.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What therapeutic strategy is evaluated in this study?","Question",{"text":112,"@type":113},"The study evaluates siRNA-loaded extracellular vesicles (siRNA@EVs) designed to target HSPD1/HSP60 for prostate cancer therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is HSP60 implicated in prostate cancer metabolism here?",{"text":117,"@type":113},"Multi-omics and experimental results show HSP60 enhances glycolysis through p53 suppression, driving metabolic reprogramming.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental models and assays were used to assess efficacy?",{"text":121,"@type":113},"The authors assess glycolysis-related readouts in vitro (e.g., glucose consumption, lactate/pyruvate production, hexokinase activity, ATP production) and evaluate tumor growth and metastasis using xenograft models in nude mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353511,1790183308,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(2): 641-662. doi: 10.7150/ijbs.120760  \nResearch Paper  \nTargeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer  \nMeng-Yao Xu1,2\\#, Sheng Ma1\\#, Si-Yang Ma1\\#, Chen-Qian Liu3, Jian-Xuan Sun1, Ye An1, Jin-Zhou Xu1, Si-Han Zhang1, Na Zeng1, Xing-Yu Zhong1, Xiao-Hua Zhu2*􀀍, Shao-Gang Wang1*􀀍, Qi-Dong Xia1*􀀍  \n1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030, Wuhan, China.  \n2. Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030, Wuhan, China.  \n3. Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.  \n\\# These three authors contributed equally to this work.  \n* These three authors contributed equally to this work.  \n􀀍 Corresponding authors: Qi-Dong Xia, [qdqd_invoker@tjh.tjmu.edu.cn](qdqd_invoker@tjh.tjmu.edu.cn); Shang-Gang Wang, [sgwangtjm@163.com](sgwangtjm@163.com); Xiao-Hua Zhu, [evazhu@vip.sina.com](evazhu@vip.sina.com); Department of Urology and Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, 430030, Wuhan, China.  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.07.02; Accepted: 2025.11.13; Published: 2026.01.01  \nAbstract  \nProstate cancer (PCa), a most prevalent urologic malignancy in men, remains a therapeutic challenge due to limited targeted strategies. This study investigates heat shock protein 60 (HSP60) (HSPD1-encoded), employing multi-dimensional approaches to decipher its oncogenic role and develop siRNA-loaded extracellular vesicles (siRNA@EVs) for PCa targeted therapy. Bioinformatics screening identified HSPD1 overexpression in PCa, which was validated via qPCR/Western blot in clinical tissues and cell lines. Metabolomic-transcriptomic integration and molecular biology experiments revealed HSP60-mediated glycolytic reprogramming. EVs were harvested from UV-irradiated PCa cells via high-speed centrifugation. siRNA@EVs were constructed via electroporation and evaluated in vitro (glycolysis phenotyping: glucose consumption, lactate/pyruvate production, hexokinase activity, and ATP production) and in vivo using xenograft models. Data were analyzed using R 4.3.1 and GraphPad Prism 9.0 (two-tailed t-test, P \u003C 0.05). Multiple bioinformatics analyses (DepMap/TCGA/HPA) confirmed that HSP60 is specifically overexpressed and associated with advanced PCa progression and poor prognosis. HSPD1 knockdown and pharmacological HSP60 inhibition suppressed proliferation, metastasis, and subcutaneous tumor growth, while overexpression exacerbated oncogenicity. Multi-omics integration revealed HSP60 enhances glycolysis via p53 suppression, driving metabolic reprogramming. siRNA@EVs achieved significant HSPD1 silencing, effectively inhibiting the proliferation and metastasis of PCa cells, and blocking xenografts tumor growth in nude mice with safety. siRNA@EVs targeting HSPD1 demonstrate precision therapeutic potential with robust efficacy and safety, offering a novel approach for targeted therapy in PCa.  \nKeywords: prostate cancer, HSP60, p53, glycolysis, extracellular vesicles  \nIntroduction  \nProstate cancer (PCa), ranking among the most prevalent malignancies in males worldwide, is characterized by high morbidity and mortality rates. Recent cancer statistics reveal that PCa accounts for  \n29","cbCailRP5ajvBZXr","https://ap.wps.com/l/cbCailRP5ajvBZXr","pdf",14062372,22,"English","# Abstract\n## Introduction","[{\"question\":\"What therapeutic strategy is evaluated in this study?\",\"answer\":\"The study evaluates siRNA-loaded extracellular vesicles (siRNA@EVs) designed to target HSPD1/HSP60 for prostate cancer therapy.\"},{\"question\":\"How is HSP60 implicated in prostate cancer metabolism here?\",\"answer\":\"Multi-omics and experimental results show HSP60 enhances glycolysis through p53 suppression, driving metabolic reprogramming.\"},{\"question\":\"What experimental models and assays were used to assess efficacy?\",\"answer\":\"The authors assess glycolysis-related readouts in vitro (e.g., glucose consumption, lactate/pyruvate production, hexokinase activity, ATP production) and evaluate tumor growth and metastasis using xenograft models in nude mice.\"}]","Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer | PDF",1790105862,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e26a529a979728461c8feb4ada56d3b1.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4de3bf8e1513c012b8e2343a9e89c5e.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4fe80c1b8352457c77db77d422f2083.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cd8669cc3c31dd9b4f7b302880d8c66.webp",980,1268]